77 related articles for article (PubMed ID: 21348197)
1. [Nonsteroidal anti-inflammatory drug NS398 induces RECK expression in the animal model of prostate cancer].
Xu ZY; Gao JP; Sun YH; Zhang ZY; Ge JP; Xu CL; Wang LH
Zhonghua Nan Ke Xue; 2010 Dec; 16(12):1079-82. PubMed ID: 21348197
[TBL] [Abstract][Full Text] [Related]
2. [Nonsteroidal anti-inflammatory drug NS398 regulates the RECK gene expression in the prostate carcinoma strain DU145].
Xu ZY; Gao JP; Sun YH; Zhang ZY; Ge JP; Xu CL; Wang LH
Zhonghua Nan Ke Xue; 2008 Apr; 14(4):303-6. PubMed ID: 18481419
[TBL] [Abstract][Full Text] [Related]
3. Induction of RECK by nonsteroidal anti-inflammatory drugs in lung cancer cells.
Liu LT; Chang HC; Chiang LC; Hung WC
Oncogene; 2002 Nov; 21(54):8347-50. PubMed ID: 12447698
[TBL] [Abstract][Full Text] [Related]
4. Non-steroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 expression via repression of transcription in lung cancer cells.
Pan MR; Chuang LY; Hung WC
FEBS Lett; 2001 Nov; 508(3):365-8. PubMed ID: 11728453
[TBL] [Abstract][Full Text] [Related]
5. Reversion-inducing-cysteine-rich protein with Kazal motif is involved in intimal hyperplasia in carotid arteries: a new insight in the prevention of restenosis after vascular angioplasty.
Liu J; Chi D; Lu H; Zhang T; Yamakawa T
Ann Vasc Surg; 2015 Aug; 29(6):1293-9. PubMed ID: 26004948
[TBL] [Abstract][Full Text] [Related]
6. Non-steroidal anti-inflammatory drugs suppress the ERK signaling pathway via block of Ras/c-Raf interaction and activation of MAP kinase phosphatases.
Pan MR; Chang HC; Hung WC
Cell Signal; 2008 Jun; 20(6):1134-41. PubMed ID: 18374541
[TBL] [Abstract][Full Text] [Related]
7. Ras induces experimental lung metastasis through up-regulation of RbAp46 to suppress RECK promoter activity.
Yeh HH; Tseng YF; Hsu YC; Lan SH; Wu SY; Raghavaraju G; Cheng DE; Lee YR; Chang TY; Chow NH; Hung WC; Liu HS
BMC Cancer; 2015 Mar; 15():172. PubMed ID: 25885317
[TBL] [Abstract][Full Text] [Related]
8. The nonsteroidal anti-inflammatory drug NS398 reactivates SPARC expression via promoter demethylation to attenuate invasiveness of lung cancer cells.
Pan MR; Chang HC; Chuang LY; Hung WC
Exp Biol Med (Maywood); 2008 Apr; 233(4):456-62. PubMed ID: 18367635
[TBL] [Abstract][Full Text] [Related]
9. Variations on brain microglial gene expression of MMPs, RECK, and TIMPs in inflammatory and non-inflammatory diseases in dogs.
Stein VM; Puff C; Genini S; Contioso VB; Baumgärtner W; Tipold A
Vet Immunol Immunopathol; 2011 Nov; 144(1-2):17-26. PubMed ID: 21802747
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
Attiga FA; Fernandez PM; Weeraratna AT; Manyak MJ; Patierno SR
Cancer Res; 2000 Aug; 60(16):4629-37. PubMed ID: 10969817
[TBL] [Abstract][Full Text] [Related]
11. NS398 protects cells from sodium nitroprusside-mediated cytotoxicity through enhancing HO-1 induction independent of COX-2 inhibition.
Nizamutdinova IT; Lee JH; Seo HG; Chang KC; Kim HJ
Arch Pharm Res; 2009 Jan; 32(1):99-107. PubMed ID: 19183882
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effect of NS398 on the proliferation of human ovarian cancer cell lines CAOV3 and OVCAR3 in vitro].
Wang CY; Wang M; Wang XY; Zhang SL; Wang YX; Li LK
Zhonghua Fu Chan Ke Za Zhi; 2003 Jul; 38(7):415-8. PubMed ID: 12921553
[TBL] [Abstract][Full Text] [Related]
13. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells.
Liu XH; Yao S; Kirschenbaum A; Levine AC
Cancer Res; 1998 Oct; 58(19):4245-9. PubMed ID: 9766645
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells.
Wen B; Deutsch E; Eschwege P; De Crevoisier R; Nasr E; Eschwege F; Bourhis J
J Urol; 2003 Nov; 170(5):2036-9. PubMed ID: 14532848
[TBL] [Abstract][Full Text] [Related]
15. Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.
Wittschieber D; Stenzinger A; Klauschen F; Stephan C; Jung K; Erbersdobler A; Rabien A
Pathobiology; 2011; 78(3):123-31. PubMed ID: 21613799
[TBL] [Abstract][Full Text] [Related]
16. [Expression and significance of the matrix metalloproteinase inhibitor RECK gene in prostate cell strains].
Xu ZY; Gao JP; Zhang ZP; Ge JP; Xu CL; Sun YH
Zhonghua Nan Ke Xue; 2005 Oct; 11(10):727-30. PubMed ID: 16281502
[TBL] [Abstract][Full Text] [Related]
17. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs.
Molina MA; Sitja-Arnau M; Lemoine MG; Frazier ML; Sinicrope FA
Cancer Res; 1999 Sep; 59(17):4356-62. PubMed ID: 10485483
[TBL] [Abstract][Full Text] [Related]
18. RECK overexpression decreases invasive potential in prostate cancer cells.
Rabien A; Ergün B; Erbersdobler A; Jung K; Stephan C
Prostate; 2012 Jun; 72(9):948-54. PubMed ID: 22025325
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis by cyclo-oxygenase-2 inhibitor NS398 through a cytochrome C-dependent pathway in esophageal cancer cells.
Li M; Wu X; Xu XC
Int J Cancer; 2001 Jul; 93(2):218-23. PubMed ID: 11410869
[TBL] [Abstract][Full Text] [Related]
20. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
Takeuchi T; Hisanaga M; Nagao M; Ikeda N; Fujii H; Koyama F; Mukogawa T; Matsumoto H; Kondo S; Takahashi C; Noda M; Nakajima Y
Clin Cancer Res; 2004 Aug; 10(16):5572-9. PubMed ID: 15328199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
